James – Talk Bio

Actionable Insights Powered by AI

House Oversight Chair Demands PBM Executives Correct False Testimonies

8 months ago talkbio0Tagged Benefit, Chairs, Comer, Congressional Hearing, House, James, manager, Pharmaceutical Services, Pharmacy Benefit Manager

PBM Executives, False Testimonies, House Oversight Chair, James Comer, Pharmacy Benefit Managers, Congressional Hearing

BioMarin Appoints Industry Veterans from Amgen and Roche in Executive Revamp

8 months ago talkbio0Tagged amgen, BioMarin, gene therapy, Greg Friberg, Hemophilia A, James, Roche (company), Roctavian, Sabry

BioMarin, executive restructuring, Amgen, Roche, Greg Friberg, James Sabry, Roctavian, hemophilia A gene therapy

BioMarin Appoints New R&D and Business Development Leaders

8 months ago talkbio0Tagged BioMarin, business career, development aspects, Fuchs, Greg Friberg, James, Leadership, R&D, Sabry

BioMarin, R&D, Business Development, Leadership, Greg Friberg, James Sabry, Hank Fuchs

James Sabry Departs Roche After 14 Years, Returns to Biotech Industry

11 months ago talkbio0Tagged biotech, career, Drug Industry, genentech, James, Partnering, Roche (company), Sabry

James Sabry, Roche, Genentech, Biotech, Partnering, Pharmaceutical Industry, Career Moves